SOPHiA GENETICS S.A.
SOPH
Cena:
$ 4.88
-0.17 (-3.37%)
Valuace
85
Růst
15
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 6.8 mil | 10.05% | 0.08% | 0.30% | 2021-09-30 |
| AKRE CAPITAL MANAGEMENT LLC | 3.7 mil | 5.51% | 0.11% | 0.30% | 2024-03-31 |
| CREDIT SUISSE AG/ | 2.2 mil | 3.32% | 0.00% | 0.01% | 2021-09-30 |
| BANQUE PICTET & CIE SA | 2.2 mil | 3.24% | 0.02% | 0.08% | 2022-03-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.9 mil | 2.74% | 0.37% | 0.37% | 2026-03-31 |
| ROYCE & ASSOCIATES LP | 1.8 mil | 2.69% | 0.07% | 0.09% | 2025-12-31 |
| PRINCIPAL FINANCIAL GROUP INC | 1.4 mil | 2.09% | 0.00% | 0.00% | 2021-09-30 |
| ALTA WEALTH ADVISORS LLC | 1.4 mil | 2.09% | 0.07% | 2.27% | 2022-06-30 |
| KENNEDY CAPITAL MANAGEMENT LLC | 927.80 tis | 1.37% | 0.10% | 0.10% | 2026-03-31 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 692.81 tis | 1.03% | 0.54% | 0.54% | 2026-03-31 |
| ENSIGN PEAK ADVISORS, INC | 444.95 tis | 0.66% | 0.00% | 0.00% | 2025-06-30 |
| ARCHON CAPITAL MANAGEMENT LLC | 441.41 tis | 0.65% | 0.06% | 1.23% | 2025-06-30 |
| HODGES CAPITAL MANAGEMENT INC. | 435.84 tis | 0.65% | 0.18% | 0.18% | 2026-03-31 |
| SEI INVESTMENTS CO | 357.89 tis | 0.53% | 0.00% | 0.00% | 2026-03-31 |
| PICTET & CIE (EUROPE) SA | 255.20 tis | 0.37% | 0.00% | 0.03% | 2022-03-31 |
| 1492 CAPITAL MANAGEMENT LLC | 225.75 tis | 0.33% | 0.05% | 0.43% | 2025-12-31 |
| LEGATO CAPITAL MANAGEMENT LLC | 216.34 tis | 0.32% | 0.10% | 0.10% | 2026-03-31 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 203.33 tis | 0.30% | 0.00% | 0.01% | 2022-06-30 |
| FEDERATED HERMES, INC. | 190.01 tis | 0.28% | 0.00% | 0.00% | 2022-12-31 |
| RATHBONES GROUP PLC | 149.13 tis | 0.22% | 0.00% | 0.00% | 2025-06-30 |
| UBS GROUP AG | 92.23 tis | 0.14% | 0.00% | 0.00% | 2021-09-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 92.15 tis | 0.14% | 0.00% | 0.00% | 2021-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 59.80 tis | 0.09% | 0.00% | 0.00% | 2022-06-30 |
| GOLDMAN SACHS GROUP INC | 57.63 tis | 0.09% | 0.00% | 0.00% | 2025-06-30 |
| SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 51.97 tis | 0.08% | 0.01% | 0.14% | 2024-12-31 |
| BANK PICTET & CIE (ASIA) LTD | 46.02 tis | 0.07% | 0.00% | 0.01% | 2022-03-31 |
| GREEN ALPHA ADVISORS, LLC | 42.95 tis | 0.06% | 0.01% | 0.21% | 2024-09-30 |
| PATHSTONE HOLDINGS, LLC | 31.47 tis | 0.05% | 0.00% | 0.00% | 2024-09-30 |
| CITADEL ADVISORS LLC | 29.20 tis | 0.04% | 0.00% | 0.00% | 2026-03-31 |
| GSA CAPITAL PARTNERS LLP | 24.97 tis | 0.04% | 0.01% | 0.01% | 2025-09-30 |
| MORGAN STANLEY | 23.18 tis | 0.03% | 0.00% | 0.00% | 2021-09-30 |
| POLEN CAPITAL MANAGEMENT LLC | 21.74 tis | 0.03% | 0.00% | 0.00% | 2025-12-31 |
| FRANKLIN RESOURCES INC | 21.56 tis | 0.03% | 0.00% | 0.00% | 2026-03-31 |
| ROYAL BANK OF CANADA | 19.38 tis | 0.03% | 0.00% | 0.00% | 2023-12-31 |
| FNY INVESTMENT ADVISERS, LLC | 16.01 tis | 0.02% | -0.05% | 0.02% | 2025-03-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.16 tis | 0.02% | 0.00% | 0.00% | 2025-09-30 |
| CENTIVA CAPITAL, LP | 12.55 tis | 0.02% | 0.00% | 0.00% | 2026-03-31 |
| XTX TOPCO LTD | 11.76 tis | 0.02% | 0.00% | 0.00% | 2025-12-31 |
| QUADRATURE CAPITAL LTD | 11.65 tis | 0.02% | 0.00% | 0.00% | 2025-12-31 |
| PERKINS CAPITAL MANAGEMENT INC | 10.50 tis | 0.02% | 0.01% | 0.05% | 2025-12-31 |
| TWO SIGMA INVESTMENTS, LP | 10.20 tis | 0.02% | 0.00% | 0.00% | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 10.14 tis | 0.02% | 0.00% | 0.00% | 2021-09-30 |
| FIRST DALLAS SECURITIES INC. | 10.00 tis | 0.01% | 0.02% | 0.02% | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 5.91 tis | 0.01% | 0.00% | 0.00% | 2025-12-31 |
| BANK OF AMERICA CORP /DE/ | 5.55 tis | 0.01% | 0.00% | 0.00% | 2025-12-31 |
| BLACKROCK INC. | 4.98 tis | 0.01% | 0.00% | 0.00% | 2021-09-30 |
| BLACKROCK, INC. | 5.09 tis | 0.01% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 4.98 tis | 0.01% | 0.00% | 0.00% | 2024-09-30 |
| ASSETMARK, INC | 4.71 tis | 0.01% | 0.00% | 0.00% | 2022-03-31 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 3.76 tis | 0.01% | 0.00% | 0.00% | 2021-09-30 |
| COMPAGNIE LOMBARD ODIER SCMA | 1.06 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| ADVISOR GROUP HOLDINGS, INC. | 1.00 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| NBC SECURITIES, INC. | 0.99 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| PARALLEL ADVISORS, LLC | 0.90 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.70 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.37 tis | 0.00% | 0.00% | 0.00% | 2025-12-31 |
| JPMORGAN CHASE & CO | 0.21 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| 0.17 tis | 0.00% | 0.00% | 0.00% | 2025-12-31 | |
| SBI SECURITIES CO., LTD. | 0.05 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| HARBOUR INVESTMENTS, INC. | 0.06 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.06 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.08 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| BANQUE CANTONALE VAUDOISE | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| COLDSTREAM CAPITAL MANAGEMENT INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| WELLS FARGO & COMPANY/MN | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| SIMPLEX TRADING, LLC | 0.03 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| CITIGROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 0.00 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| THOMPSON SIEGEL & WALMSLEY LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.00 tis | 0.00% | -0.13% | 0.00% | 2023-12-31 |
| NEWEDGE ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| MOLONEY SECURITIES ASSET MANAGEMENT, LLC | 0.00 tis | 0.00% | -0.01% | 0.00% | 2021-09-30 |
| PRINCIPAL SECURITIES, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.00 tis | 0.00% | -0.04% | 0.00% | 2022-06-30 |
| PURA VIDA INVESTMENTS, LLC | 0.00 tis | 0.00% | -0.20% | 0.00% | 2021-09-30 |
| GROUPE LA FRANCAISE | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| RIDGEWOOD INVESTMENTS LLC | 0.00 tis | 0.00% | -0.05% | 0.00% | 2024-12-31 |
| ENGINEERS GATE MANAGER LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-03-31 |
| NORDWAND ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| SAVVY ADVISORS, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| SQUAREPOINT OPS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 4000 | 4.54 | 14.5 2026 | 626888 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 5000 | 4.67 | 13.5 2026 | 256388 |
| HIBBS KATHY L | director | S-Sale | 7508 | 4.67 | 13.5 2026 | 89768 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 8500 | 5.09 | 12.5 2026 | 3633981 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 5000 | 4.82 | 28.4 2026 | 261388 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 33 | 5.08 | 21.4 2026 | 148197 |
| Muken Ross | officer: President | S-Sale | 760 | 5.20 | 21.4 2026 | 681672 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 608 | 5.20 | 21.4 2026 | 266388 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 4486 | 5.21 | 21.4 2026 | 3642481 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 684 | 5.20 | 21.4 2026 | 345736 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 608 | 5.21 | 21.4 2026 | 630888 |
| Valente Manuela | officer: Chief People Officer | S-Sale | 380 | 5.20 | 21.4 2026 | 215071 |
| Muken Ross | officer: President | S-Sale | 2800 | 4.96 | 16.4 2026 | 682432 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 1600 | 4.96 | 16.4 2026 | 266996 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 17473 | 5.00 | 16.4 2026 | 3646967 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 43129 | 4.96 | 16.4 2026 | 3664440 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 600 | 4.97 | 16.4 2026 | 631496 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 3400 | 4.76 | 14.4 2026 | 268596 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 1000 | 4.76 | 14.4 2026 | 271996 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 3725 | 4.68 | 14.4 2026 | 272996 |
| Muken Ross | officer: President | S-Sale | 4442 | 4.77 | 14.4 2026 | 685232 |
| Muken Ross | officer: President | S-Sale | 3687 | 4.69 | 14.4 2026 | 689674 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 4399 | 4.76 | 14.4 2026 | 3707569 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 3732 | 4.72 | 14.4 2026 | 3711968 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 8500 | 4.72 | 14.4 2026 | 3715700 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 3400 | 4.76 | 14.4 2026 | 632096 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 1014 | 4.76 | 14.4 2026 | 635496 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 3706 | 4.68 | 14.4 2026 | 636510 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 2400 | 4.67 | 14.4 2026 | 346420 |
| CARDOZA GEORGE | officer: Chief Financial Officer | S-Sale | 1403 | 4.85 | 10.4 2026 | 291458 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 1988 | 4.74 | 10.4 2026 | 348820 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 2861 | 4.85 | 10.4 2026 | 350808 |
| Valente Manuela | officer: Chief People Officer | S-Sale | 3824 | 4.85 | 10.4 2026 | 215451 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 1931 | 4.74 | 10.4 2026 | 276721 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 2800 | 4.84 | 10.4 2026 | 278652 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 1936 | 4.74 | 10.4 2026 | 640216 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 2800 | 4.84 | 10.4 2026 | 642152 |
| Muken Ross | officer: President | S-Sale | 1950 | 4.74 | 10.4 2026 | 693361 |
| Muken Ross | officer: President | S-Sale | 2786 | 4.84 | 10.4 2026 | 695311 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 1950 | 4.74 | 10.4 2026 | 3724200 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 2800 | 4.84 | 10.4 2026 | 3726150 |
| Verma Abhimanyu | officer: Chief Technology Officer | A-Award | 82136 | 0.00 | 8.4 2026 | 207949 |
| Xu Zhenyu | officer: Chief Scientific Officer | A-Award | 112936 | 0.00 | 8.4 2026 | 650052 |
| Valente Manuela | officer: Chief People Officer | A-Award | 71869 | 0.00 | 8.4 2026 | 224248 |
| Puylaert Kevin | officer: Chief Sales Officer | A-Award | 56468 | 0.00 | 8.4 2026 | 148854 |
| Menu Philippe | officer: Chief Medical Officer | A-Award | 112936 | 0.00 | 8.4 2026 | 286552 |
| Camblong Jurgi | director, officer: Chief Executive Officer | A-Award | 431211 | 0.00 | 8.4 2026 | 3734050 |
| CARDOZA GEORGE | officer: Chief Financial Officer | A-Award | 112936 | 0.00 | 8.4 2026 | 297794 |
| Muken Ross | officer: President | A-Award | 431211 | 0.00 | 8.4 2026 | 703121 |
| Van Well Daan | officer: Chief Legal Officer | A-Award | 97536 | 0.00 | 8.4 2026 | 358774 |
| Verma Abhimanyu | officer: Chief Technology Officer | S-Sale | 1030 | 4.87 | 8.4 2026 | 204400 |
| Verma Abhimanyu | officer: Chief Technology Officer | S-Sale | 2519 | 4.86 | 8.4 2026 | 205430 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 2400 | 4.87 | 8.4 2026 | 644952 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 2700 | 4.85 | 8.4 2026 | 647352 |
| Valente Manuela | officer: Chief People Officer | S-Sale | 2376 | 4.87 | 8.4 2026 | 219275 |
| Valente Manuela | officer: Chief People Officer | S-Sale | 2597 | 4.85 | 8.4 2026 | 221651 |
| CARDOZA GEORGE | officer: Chief Financial Officer | S-Sale | 2413 | 4.88 | 8.4 2026 | 292861 |
| CARDOZA GEORGE | officer: Chief Financial Officer | S-Sale | 2520 | 4.85 | 8.4 2026 | 295274 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 2500 | 4.86 | 8.4 2026 | 3728950 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 2600 | 4.85 | 8.4 2026 | 3731450 |
| Muken Ross | officer: President | S-Sale | 2424 | 4.87 | 8.4 2026 | 698097 |
| Muken Ross | officer: President | S-Sale | 2600 | 4.85 | 8.4 2026 | 700521 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 2400 | 4.87 | 8.4 2026 | 353669 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 2705 | 4.86 | 8.4 2026 | 356069 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 30 | 4.83 | 8.4 2026 | 148230 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 46 | 4.86 | 8.4 2026 | 148260 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 548 | 4.86 | 8.4 2026 | 148306 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 2400 | 4.87 | 8.4 2026 | 281452 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 2700 | 4.85 | 8.4 2026 | 283852 |
| Van Well Daan | officer: Chief Legal Officer | A-Award | 97536 | 0.00 | 3.4 2026 | 97536 |
| Van Well Daan | officer: Chief Legal Officer | A-Award | 142216 | 5.04 | 3.4 2026 | 142216 |
| Valente Manuela | officer: Chief People Officer | A-Award | 71869 | 0.00 | 3.4 2026 | 71869 |
| Valente Manuela | officer: Chief People Officer | A-Award | 104790 | 5.04 | 3.4 2026 | 104790 |
| CARDOZA GEORGE | officer: Chief Financial Officer | A-Award | 112936 | 0.00 | 3.4 2026 | 112936 |
| CARDOZA GEORGE | officer: Chief Financial Officer | A-Award | 164671 | 5.04 | 3.4 2026 | 164671 |
| Puylaert Kevin | officer: Chief Sales Officer | A-Award | 56468 | 0.00 | 3.4 2026 | 56468 |
| Puylaert Kevin | officer: Chief Sales Officer | A-Award | 82335 | 5.04 | 3.4 2026 | 82335 |
| Camblong Jurgi | director, officer: Chief Executive Officer | A-Award | 431211 | 0.00 | 3.4 2026 | 431211 |
| Camblong Jurgi | director, officer: Chief Executive Officer | A-Award | 628743 | 5.04 | 3.4 2026 | 628743 |
| Xu Zhenyu | officer: Chief Scientific Officer | A-Award | 112936 | 0.00 | 3.4 2026 | 112936 |
| Xu Zhenyu | officer: Chief Scientific Officer | A-Award | 164671 | 5.04 | 3.4 2026 | 164671 |
| Menu Philippe | officer: Chief Medical Officer | A-Award | 112936 | 0.00 | 3.4 2026 | 112936 |
| Menu Philippe | officer: Chief Medical Officer | A-Award | 164671 | 5.04 | 3.4 2026 | 164671 |
| Muken Ross | officer: President | A-Award | 431211 | 0.00 | 3.4 2026 | 431211 |
| Muken Ross | officer: President | A-Award | 628743 | 5.04 | 3.4 2026 | 628743 |
| Verma Abhimanyu | officer: Chief Technology Officer | A-Award | 82136 | 0.00 | 3.4 2026 | 82136 |
| Verma Abhimanyu | officer: Chief Technology Officer | A-Award | 119760 | 5.04 | 3.4 2026 | 119760 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 3 | 4.71 | 1.4 2026 | 92383 |
| CARDOZA GEORGE | officer: Chief Financial Officer | S-Sale | 774 | 4.79 | 20.3 2026 | 184858 |
| Puylaert Kevin | officer: Chief Sales Officer | S-Sale | 33 | 4.76 | 20.3 2026 | 92386 |
| Muken Ross | officer: President | S-Sale | 1183 | 4.79 | 20.3 2026 | 271910 |
| Valente Manuela | officer: Chief People Officer | S-Sale | 380 | 4.79 | 20.3 2026 | 152379 |
| Xu Zhenyu | officer: Chief Scientific Officer | S-Sale | 608 | 4.78 | 20.3 2026 | 537116 |
| Menu Philippe | officer: Chief Medical Officer | S-Sale | 608 | 4.79 | 20.3 2026 | 173616 |
| Camblong Jurgi | director, officer: Chief Executive Officer | S-Sale | 4486 | 4.77 | 20.3 2026 | 3302839 |
| Van Well Daan | officer: Chief Legal Officer | S-Sale | 684 | 4.79 | 20.3 2026 | 261238 |
| HIBBS KATHY L | director | 49751 | 3.04 | 18.3 2026 | 0 | |
| HIBBS KATHY L | director | 140000 | 5.98 | 18.3 2026 | 0 | |
| HIBBS KATHY L | director | 0 | 0.00 | 18.3 2026 | 97276 | |
| Berkovitz Tomer | director: | 0 | 0.00 | 18.3 2026 | 0 |
